Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
-3.69%
$20.46
0% positive prob.
5-Day Prediction
-4.23%
$20.34
0% positive prob.
20-Day Prediction
-3.68%
$20.46
0% positive prob.
SEC 8-K filings with transcript text
Feb 23, 2026 · 100% conf.
1D
-3.69%
$20.46
Act: +4.00%
5D
-4.23%
$20.34
Act: +0.61%
20D
-3.68%
$20.46
hstm20251021_8k.htm
false 0001095565
0001095565
2025-12-31 2025-12-31
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 23, 2026 (February 23, 2026)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 23, 2026, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2025 and provided guidance for the full year 2026, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 23, 2026, the Company issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2025 and provided guidance for the full year 2026, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On February 23, 2026, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.035 per share of the Company’s outstanding common stock, which dividend will be payable on March 20, 2026 to holders of record on March 9, 2026.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 23, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 23, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 23, 2026
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Nov 3, 2025
hstm20250819_8k.htm
false 0001095565
0001095565
2025-11-03 2025-11-03
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 3, 2025 (November 3, 2025)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 3, 2025, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On November 3, 2025 the Company issued a press release announcing results of operations for the third quarter ended September 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On November 3, 2025, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.031 per share of the Company’s outstanding common stock, which dividend will be payable on November 28, 2025 to holders of record on November 17, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated November 3, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated November 3, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: November 3, 2025
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Aug 4, 2025
hstm20250603_8k.htm
false 0001095565
0001095565
2025-08-04 2025-08-04
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 4, 2025 (August 4, 2025)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On August 4, 2025, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On August 4, 2025 the Company issued a press release announcing results of operations for the second quarter ended June 30, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On August 4, 2025, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.031 per share of the Company’s outstanding common stock, which dividend will be payable on August 29, 2025 to holders of record on August 18, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated August 4, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated August 4, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: August 4, 2025
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
May 5, 2025
hstm20250107_8k.htm
false 0001095565
0001095565
2025-05-05 2025-05-05
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 5, 2025 (May 5, 2025)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 850,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On May 5, 2025, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On May 5, 2025 the Company issued a press release announcing results of operations for the first quarter ended March 31, 2025 and updated guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On May 5, 2025, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.031 per share of the Company’s outstanding common stock, which dividend will be payable on May 30, 2025 to holders of record on May 19, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated May 5, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated May 5, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: May 5, 2025
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Feb 24, 2025
hstm20240926_8k.htm
false 0001095565
0001095565
2025-02-24 2025-02-24
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 24, 2025 (February 24, 2025)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 24, 2025, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2024 and provided guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 24, 2025, the Company issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2024 and provided guidance for the full year 2025, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On February 24, 2025, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.031 per share of the Company’s outstanding common stock, which dividend will be payable on March 21, 2025 to holders of record on March 10, 2025.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 24, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 24, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 24, 2025
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Oct 21, 2024
hstm20240809_8k.htm
false 0001095565
0001095565
2024-10-21 2024-10-21
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 21, 2024 (October 21, 2024)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 21, 2024, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2024 and updated guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On October 21, 2024 the Company issued a press release announcing results of operations for the third quarter ended September 30, 2024 and updated guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On October 21, 2024, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.028 per share of the Company’s outstanding common stock, which dividend will be payable on November 15, 2024 to holders of record on November 4, 2024.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated October 21, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated October 21, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: October 21, 2024
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Jul 22, 2024
hstm20240530c_8k.htm
false 0001095565
0001095565
2024-07-22 2024-07-22
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 22, 2024 (July 22, 2024)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 22, 2024, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2024 and updated guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On July 22, 2024 the Company issued a press release announcing results of operations for the second quarter ended June 30, 2024 and updated guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On July 22, 2024, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.028 per share of the Company’s outstanding common stock, which dividend will be payable on August 16, 2024 to holders of record on August 5, 2024.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated July 22, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated July 22, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: July 22, 2024
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Apr 22, 2024
hstm20240311_8k.htm
false 0001095565
0001095565
2024-04-22 2024-04-22
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 22, 2024 (April 22, 2024)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On April 22, 2024, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2024 and reaffirming guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On April 22, 2024 the Company issued a press release announcing results of operations for the first quarter ended March 31, 2024 and reaffirming guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On April 22, 2024, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.028 per share of the Company’s outstanding common stock, which dividend will be payable on May 17, 2024 to holders of record on May 6, 2024.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated April 22, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated April 22, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: April 22, 2024
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Feb 20, 2024
hstm20231116_8k.htm
false 0001095565
0001095565
2024-02-19 2024-02-19
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 20, 2024 (February 19, 2024)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 19, 2024, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2023 and provided guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 19, 2024, the Company issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2023 and provided guidance for the full year 2024, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On February 19, 2024, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.028 per share of the Company’s outstanding common stock, which dividend will be payable on March 22, 2024 to holders of record on March 11, 2024.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 19, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 19, 2024
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 20, 2024
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Oct 23, 2023
hstm20230829_8k.htm
false 0001095565
0001095565
2023-10-23 2023-10-23
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 23, 2023 (October 23, 2023)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 23, 2023, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2023 and updated guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On October 23, 2023 the Company issued a press release announcing results of operations for the third quarter ended September 30, 2023 and updated guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On October 23, 2023, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.025 per share of the Company’s outstanding common stock, which dividend will be payable on December 22, 2023 to holders of record on December 11, 2023.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated October 23, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated October 23, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: October 23, 2023
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Jul 24, 2023
hstm20230512_8k.htm
false 0001095565
0001095565
2023-07-24 2023-07-24
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 24, 2023 (July 24, 2023)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 24, 2023, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2023 and reaffirming guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On July 24, 2023 the Company issued a press release announcing results of operations for the second quarter ended June 30, 2023 and reaffirming guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On July 24, 2023, we announced that our Board of Directors declared a quarterly cash dividend under the Company's dividend policy in the amount of $0.025 per share of the Company’s outstanding common stock, which dividend will be payable on September 29, 2023 to holders of record on September 18, 2023.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated July 24, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated July 24, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: July 24, 2023
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Apr 24, 2023
hstm20230206_8k.htm
false 0001095565
0001095565
2023-04-24 2023-04-24
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 24, 2023 (April 24, 2023)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On April 24, 2023, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2023 and reaffirming guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure.
On April 24, 2023 the Company issued a press release announcing results of operations for the first quarter ended March 31, 2023 and reaffirming guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On April 24, 2023, we announced that the our Board of Directors declared the Company’s second quarterly cash dividend under its dividend policy in the amount of $0.025 per share of the Company’s outstanding common stock, which dividend will be payable on June 23, 2023 to holders of record on June 12, 2023.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated April 24, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated April 24, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: April 24, 2023
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Feb 21, 2023
hstm20221013_8k.htm
false 0001095565
0001095565
2023-02-20 2023-02-20
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 21, 2023 (February 20, 2023)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 20, 2023, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2022 and provided guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 20, 2023, the Company issued a press release announcing results of operations for the fourth quarter and full year ended December 31, 2022 and provided guidance for the full year 2023, the text of which is set forth in Exhibit 99.1.
Item 8.01 Other Events.
On February 20, 2023, we announced that our Board of Directors adopted a quarterly cash dividend policy, with an initial quarterly dividend of $0.025 per share, with the initial dividend being payable on April 28, 2023 to holders of record on April 17, 2023, and expected aggregate fiscal 2023 dividends of approximately $3.0 million.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 20, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 20, 2023
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 21, 2023
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Oct 24, 2022
hstm20220816_8k.htm
false 0001095565
0001095565
2022-10-24 2022-10-24
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 24, 2022 (October 24, 2022)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 24, 2022, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2022 and updated guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On October 24, 2022 the Company issued a press release announcing results of operations for the third quarter ended September 30, 2022 and updated guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated October 24, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated October 24, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: October 24, 2022
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Jul 25, 2022
hstm20220519_8k.htm
false 0001095565
0001095565
2022-07-25 2022-07-25
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 25, 2022 (July 25, 2022)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 25, 2022, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2022 and reaffirming guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On July 25, 2022 the Company issued a press release announcing results of operations for the second quarter ended June 30, 2022 and reaffirming guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated July 25, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated July 25, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: July 25, 2022
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Apr 25, 2022
hstm20220303_8k.htm
false 0001095565
0001095565
2022-04-25 2022-04-25
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 25, 2022 (April 25, 2022)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On April 25, 2022, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2022 and reiterates guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On April 25, 2022, the Company issued a press release announcing results of operations for the first quarter ended March 31, 2022 and reiterates guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated April 25, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated April 25, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: April 25, 2022
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Feb 22, 2022
hstm20211230_8k.htm
false 0001095565
0001095565
2022-02-21 2022-02-21
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 22, 2022 (February 21, 2022)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 21, 2022, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the fourth quarter and full-year ended December 31, 2021 and provided guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On February 21, 2022, the Company issued a press release announcing results of operations for the fourth quarter and full-year ended December 31, 2021 and provided guidance for the full year 2022, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated February 21, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated February 21, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: February 22, 2022
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Oct 25, 2021
hstm20210924_8k.htm
false 0001095565
0001095565
2021-10-25 2021-10-25
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 25, 2021 (October 25, 2021)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 25, 2021, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the third quarter ended September 30, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On October 25, 2021, the Company issued a press release announcing results of operations for the third quarter ended September 30, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated October 25, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated October 25, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: October 25, 2021
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Jul 26, 2021
hstm-8k_20210726.htm
false 0001095565
0001095565
2021-07-26 2021-07-26
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 26, 2021 (July 26, 2021)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 26, 2021, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On July 26, 2021, the Company issued a press release announcing results of operations for the second quarter ended June 30, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated July 26, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated July 26, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: July 26, 2021
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
Apr 26, 2021
hstm-8k_20210426.htm
false 0001095565
0001095565
2021-04-26 2021-04-26
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 26, 2021 (April 26, 2021)
HealthStream, Inc.
(Exact name of Registrant as Specified in Its Charter)
Tennessee
000-27701
62-1443555
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
500 11th Avenue North, Suite 1000,
Nashville, Tennessee
37203
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 615-301-3100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock (Par Value $0.00)
Nasdaq Global Select Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On April 26, 2021, HealthStream, Inc. (the “Company”) issued a press release announcing results of operations for the first quarter ended March 31, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 7.01 Regulation FD Disclosure
On April 26, 2021, the Company issued a press release announcing results of operations for the first quarter ended March 31, 2021 and updated guidance for the full year 2021, the text of which is set forth in Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1*
Press release dated April 26, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Exhibit Index
Exhibit
Number
Description
99.1*
Press release dated April 26, 2021
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
*
Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HealthStream, Inc.
Date: April 26, 2021
By:
/s/ Scott A. Roberts
Scott A. Roberts
Chief Financial Officer
This page provides HealthStream Inc. (HSTM) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on HSTM's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.